Aviron Message Board - Msg: 1890404

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aviron

AVIR 2.955

-3.4%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nelli who wrote (86)	8/2/1997 9:41:00 AM
From: Haolin Ni	of 645

Hi, Wu, You are right the battle of AVIR is a long one, as soon as Brad gave his first post I noticed that, but I'm sure shorters will win in end. However, we need modify our plan slightly because there are obvious price manipulations in AVIR. The spread is huge most of the market time. The buy recomdation of H&Q was annouced same day as AVIR filed for secondary offering. The price went up without any news. Yestoday, 40,000 shares traded in middle day no price change but price went up in the end with little volume. So many "experts" are posting in this once quite thread. Etc, etc... However, AVIR is not a tech stock but a biotech. Everything of this company has been published before and there is no secret to the public because the products of biotech compay need FDA approval. Most of the experts know its potential even before the clinical trial was announced. No biotech stock can be doubled without great new after the price has gone up 300% in a short time. The market sentment is changing now. AVIR will not be second DNA (Diana Corp, hyped by H&Q before). I also think the time to short more will be after company announce finished secondary offering. Good luck!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next